ArticleHeart rhythm O22024
Sex differences in the prognosis of nonsustained ventricular tachycardia detected on Holter recording.
Article in Heart rhythm O2, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nonsustained ventricular tachycardia (NSVT) is a common finding during cardiac evaluation and has been linked to increased mortality. While some studies report a sex difference, most data stem from research cohorts. Objective: This study aimed to assess the prognostic significance of NSVT in a real-life outpatient clinic, focusing on sex differences in mortality. Methods: Analysis was performed on a cohort of consecutive patients referred to 48-hour Holter monitoring between 2009 and 2011 at Copenhagen University Hospital - Bispebjerg. Indications for Holter monitoring included palpitations, dizziness, syncope, or arrhythmia testing. Baseline characteristics, blood tests, echocardiography results, and mortality data were obtained from electronic patient records. Results: A total of 762 females (mean age 59 ± 18 years) and 693 males (mean age 59 ± 17 years) were enrolled. At least 1 episode of NSVT was detected in 9.7% of females and 20.6% of males. The median follow-up was 8.3 years. A total of 20% of females and 24% of males died during follow-up. In multivariable models, NSVT was linked to mortality in males (hazard ratio [HR] 1.6, 95% confidence interval [CI] 1.1-2.3) but not in females (HR 1.2, 95% CI 0.7-2.1). In case-control pairs matched on the propensity of being male conditional on relevant risk factors, NSVT was again linked to mortality in males (HR 3.1, 95% CI 2.0-4.8) but not in females (HR 1.4, 95% CI 0.8-2.4). Conclusion: In consecutive patients referred to symptom driven Holter monitoring, NSVT was associated with elevated all-cause mortality in males but not in females. These results can contribute to the risk assessment of patients presenting with NSVT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.